Related Experiment Video
Updated: Jun 5, 2026

Use of Viral Entry Assays and Molecular Docking Analysis for the Identification of Antiviral Candidates against Coxsackievirus A16
Published on: July 15, 2019
Coxsackievirus B3-associated aseptic meningitis: an emerging infection in Hong Kong
Ann H Wong1, C S Lau, Peter K C Cheng
1Virology Division, Public Health Laboratory Services Branch, Centre for Health Protection, Department of Health, Hong Kong SAR, China.
Abstract:
Enterovirus (EV) infection is a common disease of childhood and associated not uncommonly with aseptic meningitis. In the summer of 2008, laboratory surveillance has detected increased number of coxsackievirus B3 (CVB3) associated aseptic meningitis in Hong Kong, constituting 11.6% of those infected. This study analyzed the epidemiology, circulating pattern, and clinical presentations of CVB3 in Hong Kong over the last 10 years with reference to the circulation of EV in the locality. Enteroviruses (EV) were isolated from respiratory, cerebrospinal fluid (CSF), stool, and vesicular samples using human rhabdomyosarcoma, human laryngeal carcinoma (HEp2-C), human lung fibroblast (MRC-5), and African green monkey kidney (Vero) cell lines. Virus isolates were identified and characterized by indirect immunofluorescence (IF) using monoclonal antibodies (mAB), neutralization test as well as partial VP1 sequencing. Different from previous years, IF test result showed that majority of the isolates from 2008 were untypeable by the mAB suggesting antigenic change. Sequence analysis revealed that these isolates were clustered with recent isolate from Fuyang, China. Review of data from 1999 to 2008 showed increased activity of CVB3 in the years 2005 and 2008, and isolates in these 2 years displayed an amino acid change from threonine to alanine at codon 277 of the VP1 gene, which may be associated with central nervous system (CNS) disease.
Insights
An increase in coxsackievirus B3 (CVB3) caused aseptic meningitis was observed in Hong Kong. This enterovirus (EV) showed potential antigenic changes and a specific VP1 gene mutation linked to central nervous system disease.
Area of Science:
- Virology
- Epidemiology
- Public Health
Background:
- Enterovirus (EV) infections are common in children, often leading to aseptic meningitis.
- A notable increase in coxsackievirus B3 (CVB3) associated aseptic meningitis cases was detected in Hong Kong during the summer of 2008.
- This rise represented 11.6% of all infected individuals during the surveillance period.
Purpose of the Study:
- To analyze the 10-year epidemiology and circulating patterns of CVB3 in Hong Kong.
- To investigate the clinical presentations of CVB3-associated aseptic meningitis.
- To understand the local circulation of Enteroviruses (EV) in relation to CVB3 activity.
Main Methods:
- Enteroviruses (EV) were isolated from various clinical samples using multiple cell lines (HEp2-C, MRC-5, Vero).
- Virus identification and characterization involved indirect immunofluorescence (IF) with monoclonal antibodies (mAB), neutralization tests, and partial VP1 gene sequencing.
- Epidemiological data from 1999 to 2008 were reviewed.
Main Results:
- A majority of 2008 CVB3 isolates were untypeable by mAB, suggesting antigenic variation.
- Sequence analysis indicated clustering of 2008 isolates with a recent strain from Fuyang, China.
- CVB3 activity peaked in 2005 and 2008, with isolates from these years showing a T-to-A amino acid change at VP1 codon 277, potentially linked to central nervous system (CNS) disease.
Conclusions:
- The study highlights increased CVB3 activity and potential antigenic changes in Hong Kong between 1999-2008.
- A specific VP1 gene mutation (T277A) in CVB3 isolates may be associated with increased neurovirulence and CNS disease.
- Ongoing surveillance and molecular characterization are crucial for understanding EV dynamics and informing public health responses.
Related Concept Videos
Viral Meningitis
Bacterial Meningitis I: Introduction
Cryptococcal Meningitis
Bacterial Meningitis
Bacterial Meningitis II: Pathophysiology
Arboviral Encephalitis
